CARL
Carlsmed, Inc.
18.60
+3.89 (+26.44%)
52w low 8.50
17.23 high
100.0% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Total Revenue | 13.78M | 27.16M | 50.51M | |
| Cost of Revenue | 3.88M | 7.12M | 12.47M | |
| Gross Profit | 9.90M | 20.05M | 38.04M | |
| Operating Expenses | 28.49M | 44.17M | 68.61M | |
| R&D | 7.39M | 14.30M | 17.02M | |
| SG&A | 21.10M | 29.87M | 51.59M | |
| Operating Income | -18.59M | -24.12M | -30.57M | |
| EBITDA | -18.12M | -22.79M | -27.92M | |
| Pretax Income | -18.90M | -24.26M | -29.63M | |
| Net Income | -18.90M | -24.26M | -29.63M | |
| EPS Diluted | -0.99 | -6.11 | -2.12 | |
| Diluted Shares | 19.17M | 4.07M | 14.22M |
Revenue CAGR
+91.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+85.9%